VR Logo

Unrated

Tata India Pharma & HealthCare Fund - Regular Plan


1 Lakh

Investment declined to
₹ 0.99 Lakh

₹ 10000

Monthly SIP Grown to
₹ 3.73 Lakh

Analyst's Choice?

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends paid by the mutual fund scheme are taxed at the rate of 10% (effectively 11.648%, including surcharge and cess). This is known as Dividend Distribution Tax (DDT). Though the investor does not pay this tax directly, it is deducted from the dividend income before passing on to the investor.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund -0.60 3.92 8.49 -7.01 -1.69 4.58 1.41 -0.32 -- -- --
S&P BSE Healthcare TRI -7.34 3.56 6.59 -10.83 -8.38 0.86 -11.92 -6.41 -- -- --
Equity: Sectoral-Pharma -2.86 3.17 6.33 -8.91 -3.81 6.03 -0.34 -1.73 -- -- --
Rank within category 1 2 1 1 1 8 4 2 -- -- --
Number of funds in category 9 9 9 9 9 9 8 4 3 3 3

As on 03-Apr-2020

Best & Worst Performance

Best (Period) Worst (Period)
Week 8.49 (27-Mar-2020 - 03-Apr-2020) -11.13 (05-Mar-2020 - 12-Mar-2020)
Month 10.33 (20-Jul-2018 - 21-Aug-2018) -18.44 (20-Feb-2020 - 23-Mar-2020)
Quarter 22.21 (05-Jun-2018 - 04-Sep-2018) -14.66 (26-Sep-2016 - 26-Dec-2016)
Year 22.48 (06-Sep-2017 - 06-Sep-2018) -18.70 (08-Sep-2016 - 08-Sep-2017)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund 0.55 15.73 -0.32 -0.45 0.82 3.97
S&P BSE Healthcare TRI -5.34 18.13 -0.60 -1.07 -- --
Equity: Sectoral-Pharma -0.97 15.89 -0.40 -0.64 0.83 2.57
Rank within category 2 2 2 2 2 2
Number of funds in category 4 4 4 4 4 4

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Mar-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 17
Top 10 Stocks (%) 84.83
Top 5 Stocks (%) 56.20
Top 3 Sectors (%) 99.48
Portfolio P/B Ratio 3.86
Portfolio P/E Ratio 30.63

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 27,556 22,876
Giant (%) -- 1.78
Large (%) 48.32 37.31
Mid (%) 39.65 48.19
Small (%) 12.03 14.30
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Dr. Reddy's Lab Healthcare 30.73 15.59 0.00 15.58
down Abbott India Healthcare 56.51 11.41 1.74 11.41
equal Divi's Laboratories Healthcare 39.72 10.58 0.00 10.58
equal Sun Pharmaceutical Inds. Healthcare 22.54 23.13 5.93 10.51
equal Lupin Healthcare -- 12.20 0.00 8.13
equal Ipca Laboratories Healthcare 28.27 11.01 2.32 7.82
equal Procter & Gamble Health Healthcare 40.41 7.30 0.00 6.57
equal Apollo Hospitals Healthcare 51.64 6.51 1.51 6.51
down Alkem Laboratories Healthcare 24.54 6.44 0.00 3.92
down Alembic Pharmaceuticals Healthcare 13.92 6.16 3.81 3.81
equal Cadila Healthcare Healthcare 22.62 8.35 0.00 3.41
down Aurobindo Pharma Healthcare 8.73 8.81 1.53 3.06
equal Healthcare Global Enterprises Healthcare -- 5.13 0.00 2.75
new Narayana Hrudayalaya Healthcare 37.80 1.86 0.00 1.86
equal Syngene International Healthcare 25.65 7.99 0.00 1.51
equal Dr. Lal Pathlabs Healthcare 46.39 2.59 0.00 1.28
equal Astrazeneca Pharma India Healthcare 82.94 0.80 0.00 0.78

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 29-Feb-2020

Fund Manager

— Sailesh Jain since 09-Nov-2018

Education: Mr. Jain is a Commerce Graduate and an MBA.

Experience: Prior to joining TATA Mutual Fund, he has worked with Invesco Mutual Fund, IDFC Securities Ltd. as Head Derivatives, Quant Broking Pvt Ltd. as Vice President and IIFL(India Infoline) as Vice President.

Funds Managed:

— Meeta Shetty since 09-Nov-2018

Education: Ms. Shetty is Bachelor in Economics and CFA Charterholder

Experience: Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.

Funds Managed:


3.92%

Change from previous, NAV as on 03-Apr-2020

Growth: ₹ 9.1505

Dividend: ₹ 9.1505


Investment Strategy

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 150
Minimum No of Cheques 12
Minimum Withdrawal (₹) 500
Minimum Balance (₹) 500
Exit Load 0.25% for redemption within 91 days

Basic Details

Fund House: Tata Mutual Fund
Launch Date: 28-Dec-2015
Return Since Launch: -2.06%
Benchmark: NIFTY Pharma TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 165 Cr (As on 29-Feb-2020)
Expense: 2.54% (As on 29-Feb-2020)
Risk Grade: --
Return Grade: --
Turnover: 32.11%

Contact Information

AMC: Tata Asset Management Private Ltd

Address: 9th Floor, Mafatlal Centre, Nariman Point, Mumbai - 400021

Phone: 1800-209-0101

Email: [email protected]

Website: www.tatamutualfund.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Last Session

Investors' Hangout

5 ways to deal with market panic

dateFriday, 20-Mar-2020
time12:30 PM - 01:00 PM

Registration Over